A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to new research led by investigators at the Bloomberg–Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation...
retrieved 9 November 2023 from https://medicalxpress.com/news/2023-11-pathologic-scoring-lung-tumor-therapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Apr 6, 2023 Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coventry University Institute relaunches with metaverse eventCoventry University's Advanced Manufacturing and Engineering labs re-opens after a £6m expansion.
Read more »
Researchers discover unique differences in cancer cells based on where they are in a tumorUCalgary researchers have discovered unique differences in cancer cells based on where they are in a tumor. The findings indicate the cells at the edge of a tumor may hold the key to guide treatment.
Read more »
Immunotherapy plus an investigational cancer drug improves anti-tumor effectsAn investigational therapy for solid tumors could be especially effective when combined with immunotherapy to target a specific kind of cancer cell, a research team at Duke and Harvard have found.
Read more »
'Double strike' strategy slows growth of drug-resistant breast cancer, study showsResearchers at the Center for Genomic Regulation and Vall d'Hebron Institute of Oncology have shown that the simultaneous inhibition of two different proteins may represent a new strategy for tackling triple-negative breast cancer, the most aggressive and drug-resistant form of breast cancer.
Read more »
Simultaneous inhibition of two proteins may be a new strategy for tackling triple-negative breast cancerResearchers at the Centre for Genomic Regulation and Vall d'Hebron Institute of Oncology have shown that the simultaneous inhibition of two different proteins may represent a new strategy for tackling triple-negative breast cancer, the most aggressive and drug-resistant form of breast cancer.
Read more »
Gene expression in nearby healthy tissue may be a better predictor of lung cancer recurrenceGenetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center.
Read more »